Physician profile
Ellen E Sugarek
NPI 1831372259
$5,558.74
in general payments reported to CMS, 2019-2025
27 companies · $860 in 2025
The $860 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,219 · 2022: $1,110 · 2023: $1,003 · 2024: $1,366 · 2025: $860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,229.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $894.77 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $601.31 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $594.80 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $521.01 | 2021-2025 | Camzyos, Eliquis |
| Baxter Healthcare | $387.08 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $368.64 | 2021-2025 | |
| Boston Scientific Corporation | $327.47 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Merck Sharp & Dohme LLC | $234.70 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.14 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $198.26 | 2024-2025 | Ozempic, Rybelsus |
| Abiomed | $184.60 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $176.92 | 2024-2025 | Assure Wcd |
| Abbott Laboratories | $142.05 | 2023-2025 | Confirm Rx, Aveir, Amplatzer Amulet |
| Kiniksa Pharmaceuticals International, Plc | $120.31 | 2024 | Arcalyst |
| Medtronic, INC. | $102.30 | 2023-2024 | Micra, Azure Xt Dr Mri Surescan, Mycarelink |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $85.19 | 2023-2024 | Onpattro |
| Janssen Pharmaceuticals, INC | $63.46 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $54.84 | 2023 | Farxiga |
| Irhythm Technologies, INC. | $54.70 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Esperion Therapeutics, INC. | $48.11 | 2021-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $44.87 | 2022-2023 | |
| Atricure, INC. | $39.69 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $34.49 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $28.44 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $17.49 | 2022 | |
| Daiichi Sankyo INC. | $16.54 | 2024 | Injectafer |
| Amryt Pharma Holdings LTD | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Sugarek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.